Same Indication

Losartan vs Pembrolizumab

Losartan vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Losartan and Pembrolizumab.

Mechanism of Action

Losartan: Angiotensin II receptor type 1 antagonist.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Losartan β€” 2 hours; Pembrolizumab β€” 26 days.

Chemical Properties

Molecular Formula: Losartan β€” C22H23ClN6O.

Molecular Weight: Losartan β€” 422.9200 g/mol.

Type: Losartan β€” Small molecule; Pembrolizumab β€” Antibody.